Volume 4,Issue 2
Objective: To evaluate the differential diagnostic efficacy of magnetic resonance imaging (MRI) combined with ultrasound elastography (UE) for breast cancer. Methods: A total of 120 patients diagnosed with breast cancer admitted to the hospital from January 2023 to January 2025 were selected for MRI and UE diagnosis, and the differences in diagnostic efficacy between single and combined diagnostic methods were assessed. Results: The detection rate of breast cancer with combined diagnosis was higher than that with single diagnosis, and the detection rate of disease types with combined diagnosis was also higher than that with single diagnosis (P < 0.05). In terms of tumor classification, the detection rate calculated by combined diagnosis was significantly higher, and the accuracy and sensitivity obtained by combined diagnosis were high, with a low missed diagnosis rate determined, and P < 0.05 when comparing various methods. Conclusion: MRI combined with UE demonstrates superior efficacy in diagnosing breast cancer, enabling the differentiation of disease types and determination of tumor classification, with high diagnostic performance.